Peripheral T-Cell Lymphoma Market to Observe Growth at a CAGR of 4.9% in the US by 2032 | DelveInsight
21 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Peripheral T-Cell Lymphoma Market to Observe Growth at a CAGR of 4.9% in the US by 2032 | DelveInsight The rapid growth in the peripheral T-cell...
Advanced Gastric Carcinoma Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Developing Drugs for the Market Entry | DelveInsight
20 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Advanced Gastric Carcinoma Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Developing Drugs for the Market Entry The...
Major Depressive Disorder Market to Register Stunning Growth During the Forecast Period (2023–2032), Examines DelveInsight | Leading Companies - Otsuka, Sumitomo, COMPASS, Sage, Neurocrine, Boehringer Ingelheim, Janssen
16 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Major Depressive Disorder Market to Register Stunning Growth During the Forecast Period (2023–2032), Examines DelveInsight | Leading Companies -...
Intratumoral Cancer Therapies Market to Observe Stupendous Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Players - Nanobiotix, Sirnaomics, Apexigen, Replimune, Merck, OncoSec, DNAtrix, Treovir Istari
15 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Intratumoral Cancer Therapies Market to Observe Stupendous Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Players -...
Hypertrophic Cardiomyopathy Treatment Market to Exhibit Impressive Growth by 2023, Predicts DelveInsight | Key Companies - Cytokinetics, Bristol-Myers Squibb, Imbria Pharmaceuticals, Inc., Tenaya Therapeutics, Novartis
14 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Hypertrophic Cardiomyopathy Treatment Market to Exhibit Impressive Growth by 2023, Predicts DelveInsight | Key Companies - Cytokinetics,...
Myositis Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
13 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Myositis Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses...
Hunter Syndrome Market to Register Stunning Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - Denali Therapeutics Inc., JCR Pharmaceuticals Co., Ltd., REGENXBIO Inc., Shire, Takeda
09 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hunter Syndrome Market to Register Stunning Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - Denali Therapeutics Inc., JCR...
Glaucoma Market to Accelerate Substantially During the Forecast Period (2023–2032), Examines DelveInsight | Leading Companies - Nicox, SPARC, Visiox, Glaukos, Ono, Santen, Ocular, Tarsier, Peregrine Ophthalmic, Ocuphire
08 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Glaucoma Market to Accelerate Substantially During the Forecast Period (2023–2032), Examines DelveInsight | Leading Companies - Nicox, SPARC, Visiox,...
Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market - Prokidney, Inversago, Palatin Technologies, Lexicon, Daiichi Sankyo, CSL Behring
07 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market - Prokidney, Inversago,...
Complement 3 Glomerulopathy Market to Witness an Upsurge in Growth by 2023, Predicts DelveInsight | Key Companies to Watch - Novartis, Apellis, NovelMed, Amyndas, Arrowhead
06 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Complement 3 Glomerulopathy Market to Witness an Upsurge in Growth by 2023, Predicts DelveInsight | Key Companies to Watch - Novartis, Apellis,...